相关实验视频

Updated: Jul 8, 2025

Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy
06:51

Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy

Published on: December 17, 2019

15.1K

化学抗原受体T细胞疗法在风湿病学:B细胞枯竭2.0

Rohith Appalaneni1, Nikhila Achanta, Chandra Mohan

  • 1Department Biomedical Engineering, University of Houston, Houston, Texas, USA.

Current opinion in rheumatology
|December 15, 2023
PubMed
概括

针对CD19的化学抗原受体T细胞 (CAR-T) 疗法通过耗尽B细胞在风湿病学方面显示出前景. 目前正在进行的试验正在评估其在自身免疫性疾病中的有效性和安全性.

更多相关视频

A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells08:46

A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells

Published on: November 12, 2019

53.3K
Generation of Human Chimeric Antigen Receptor Regulatory T Cells10:29

Generation of Human Chimeric Antigen Receptor Regulatory T Cells

Published on: January 3, 2025

1.4K

相关概念视频

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
529